Impaired cardiopulmonary test performance as a marker of early functional impairment in patients with Anderson-Fabry disease

• Hauptverfasser: Sergio Caravita (Verfasst von), Ilaria Tanini (Verfasst von), Lia Crotti (Verfasst von), Claudia Baratto (Verfasst von), Gianfranco Parati (Verfasst von), Francesco Fattirolli (Verfasst von), Iacopo Olivotto (Verfasst von), Franco Cecchi (Verfasst von)
• Format: Buch
• Veröffentlicht: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2021-11-04.
• Schlagworte: Short Communication
• Online-Zugang: Connect to this object online.

<p>Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disease characterized by progressive glicosphingolipid accumulation in multiple organs, due to α-galactosidase a deficiency [1]. It is considered a rare disease although newborn genetic screening showed non-negligible prevalence...